Table 2.
Structural assessment of the functional site predictions.1
LeuTAa | rGAT1 | rSERT | hDAT | Structural location | Description | Experimental evidence | Predicted by2 |
(a.) Substrate/Na+-binding sites | |||||||
G20 | G59+ | G94+ | G75 | TM1a | Na+ binding site | [2–95] | P,S,R,E |
N21 | Y60+ | Y95+ | F76+ | TM1a | Leu binding site | [94–99] | None |
A22 | A61 | A96 | A77 | TM1a | Leu & Na+ binding sites | None | F,R |
V23 | I62+ | V97 | V78 | Unwound TM1 | Na+ binding site | [95] | F |
G24 | G63+ | D98+ | D79+ | Unwound TM1 | Leu binding site | [95, 97, 100, 101] | F,R,E,D |
L25 | L64+ | L99+ | L80+ | TM1b | Leu binding site | [92, 95, 102] | P,F,S,R,E |
G26 | G65+ | G100+ | A81 | TM1b | Leu binding site | [92, 95] | P,F,S,R |
N27 | N66+ | N101+ | N82 | TM1b | Na+ binding site | [92, 95] | P,F,S,R,E |
E62 | E101+ | E136+ | E117+ | TM2 | Stabilizes TM6 unwound region | [55–58] | P,F,S,R,E |
V104 | L136- | I173+ | V152+ | TM3 | Leu binding site | [93, 96, 103–105] | None |
Y108 | Y140+ | Y176+ | Y156+ | TM3 | Leu binding site | [106–108] | F,S,R |
F252 | F293 | F334 | C319+ | TM6a | Leu binding site | [109] | P,F,S,R |
F253 | F294+ | F335+ | F320+ | TM6a | Leu binding site | [93, 98, 103, 110] | P,F,S |
T254 | S295+ | S336 | S321+ | TM6a | Leu & Na+ binding sites | [108, 110, 111] | P,F,E |
S256 | G297 | G338 | G323+ | Unwound TM6 | Leu binding site | [112] | P,F,E |
L257 | L298+ | P339+ | V324 | Unwound TM6 | Leu binding site | [110, 113] | P |
G258 | G299 | G340 | G325+ | Unwound TM6 | Leu binding site | [98] | P |
F259 | L300 | F341+ | F326- | Unwound TM6 | Leu binding site | [93, 98, 103] | P |
G260 | G301 | G342 | G327+ | Unwound TM6 | Leu binding site | [112] | P,S,E |
N286 | N327+ | N368 | N353 | TM7 | Na+ binding site | [111, 114] | P,F,R |
A351 | L392 | L434 | L418 | TM8 | Na+ binding site | None | F,R,E,D |
T354 | D395+ | D437 | D42+ | TM8 | Na+ binding site | [111, 115] | P,F,R,E,D |
S355 | S396+ | S438+ | S422 | TM8 | Leu & Na+ binding sites | [93, 103, 111] | P,F,S,D |
I359 | T400 | G442+ | G426 | TM8 | Leu binding site | [93, 103] | None |
(b.) Cytoplasmic gate | |||||||
R5 | R44+ | R70 | R60+ | Cytoplasmic gate | [116] | S | |
W8 | W47+ | W82 | W63+ | Cytoplasmic gate | [58, 116] | S | |
S267 | S308 | S349 | S334 | Cytoplasmic gate | None | S,R,E | |
Y268 | Y309- | Y350 | Y335+ | Cytoplasmic gate | [57, 106, 115] | S,E | |
D369 | D410 | D452 | D436+ | Cytoplasmic gate | [58, 115] | S,E | |
(b.) Extracellular/periplasmic gate | |||||||
R30 | R69+ | R104+ | R85+ | TM1b | Extracellular gate | [57, 92, 95, 97, 117] | P,F,S,R,E |
Y47 | Y86+ | Y121 | Y102+ | TM2 | Extracellular gate | [106, 108] | P,F,S,R,E |
Q250 | Q291+ | Q332 | Q317+ | TM6a | Extracellular gate | [57, 108, 110] | P,F,S,R,E |
E290 | S331+ | S372 | L355 | TM7 | Extracellular gate | [111, 114] | P |
D404 | D451 | E493+ | D476+ | TM10 | Extracellular gate | [58, 104] | P,S |
1 The importance of the functional site benchmark has been clearly established by Yamashita et al. from the LeuTAa structure [10]. Residue numbers correspond to those of LeuTAa, rGAT1, rSERT, and hDAT (columns 1–4, respectively). Residues shown in bold with + are those whose functional role is supported by experimental data. Residues shown in bold with - are those whose functional role is not supported by experimental data. Our literature search failed to find mutagenesis evidence for residues without boldface. The criterion for positive experimental confirmation was a minimum of two-fold reduction in substrate uptake rate and/or affinity of the single site mutant compared to WT.2 Six unique bioinformatic approaches were utilized in order to predict functional sites within the NSS family. The methods employed are: P = phylogenetic motif, F = false positive expectation, S = site conservation, R = Rate4Site, E = evolutionary trace, and D = SDPpred.